这是附加信息
Description
CJC-1295 with DAC is a synthetic modified peptide compound engineered for laboratory research. The molecule features a Drug Affinity Complex (DAC) modification that enhances its stability in experimental conditions. Laboratory research demonstrates specific molecular pathway interactions and distinct binding properties in controlled models. The compound is designed with a 30-amino acid sequence structure, showing selective receptor affinity in vitro studies. The DAC modification allows for extended stability in solution compared to the non-modified variant, making it particularly suitable for prolonged laboratory studies.
Pulsatile Signaling Precision: "Engineered for high-fidelity studies of natural growth hormone-releasing hormone (GHRH) pulses without sustained elevation."
No-DAC Half-Life Optimization: "Optimized for short-term biological interaction, allowing for precise control over research intervals and metabolic observation."
99%+ Synthesis Purity: "Each batch is HPLC-verified to ensure 99.2% purity, ensuring consistent binding affinity in endocrine receptor models."
Properties
-
Molecular Code: CND-10 / GHRH Analog
-
Modification: Without DAC (Drug Affinity Complex)
-
Purity: ≥ 99.2% (HPLC Verified)
-
Research Focus: Endocrine pulsatility, circadian metabolic regulation, and lipid oxidation pathways.
You have successfully commented, please wait for review
Copied Successfully
You can enjoy up to 1 free gift!